Technical Analysis for SGMT - Sagimet Biosciences Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 9.00 | -7.50% | -0.73 |
SGMT closed down 4.14 percent on Friday, September 22, 2023, on approximately normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bearish Signal Line Cross | Bearish | -7.50% | |
| New 52 Week Closing Low | Bearish | -7.50% | |
| New 52 Week Low | Weakness | -7.50% | |
| Multiple of Ten Bearish | Other | -7.50% | |
| Below Lower BB | Weakness | -7.50% | |
| Down 3 Days in a Row | Weakness | -7.50% | |
| Oversold Stochastic | Weakness | -7.50% | |
| 20 DMA Resistance | Bearish | -11.33% | |
| New 52 Week Closing Low | Bearish | -11.33% | |
| Expansion Breakdown | Bearish Swing Setup | -11.33% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Down 5% | 10 minutes ago |
| Down 3% | 10 minutes ago |
| Fell Below Previous Day's Low | 10 minutes ago |
| Down 2 % | 10 minutes ago |
| Down 1% | 10 minutes ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/30/2023
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors to treat important diseases, such as non-alcoholic steatohepatitis, acne, and various cancers. It offers Denifanstat, a fatty acid synthase inhibitor for the treatment of nonalcoholic steatohepatitis. The company also develops TVB-3567, a FASN inhibitor. Sagimet Biosciences Inc. was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. The company was incorporated in 2006 and is based in San Mateo, California.
Keywords: Biopharmaceutical Cancer Steatohepatitis Hepatitis Non Alcoholic Fatty Liver Disease Acne
Classification
Keywords: Biopharmaceutical Cancer Steatohepatitis Hepatitis Non Alcoholic Fatty Liver Disease Acne
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 18.17 |
| 52 Week Low | 9.53 |
| Average Volume | 144,318 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 13.72 |
| 20-Day Moving Average | 11.74 |
| 10-Day Moving Average | 11.54 |
| Average True Range | 0.95 |
| RSI (14) | 26.47 |
| ADX | 18.54 |
| +DI | 10.65 |
| -DI | 26.32 |
| Chandelier Exit (Long, 3 ATRs) | 10.72 |
| Chandelier Exit (Short, 3 ATRs) | 12.38 |
| Upper Bollinger Bands | 13.05 |
| Lower Bollinger Band | 10.42 |
| Percent B (%b) | -0.26 |
| BandWidth | 22.36 |
| MACD Line | -0.80 |
| MACD Signal Line | -0.72 |
| MACD Histogram | -0.0736 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 10.68 | ||||
| Resistance 3 (R3) | 10.71 | 10.44 | 10.52 | ||
| Resistance 2 (R2) | 10.44 | 10.20 | 10.42 | 10.46 | |
| Resistance 1 (R1) | 10.08 | 10.05 | 9.95 | 10.05 | 10.41 |
| Pivot Point | 9.81 | 9.81 | 9.74 | 9.79 | 9.81 |
| Support 1 (S1) | 9.45 | 9.57 | 9.32 | 9.42 | 9.05 |
| Support 2 (S2) | 9.18 | 9.42 | 9.16 | 9.00 | |
| Support 3 (S3) | 8.82 | 9.18 | 8.94 | ||
| Support 4 (S4) | 8.79 |
